These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15636177)

  • 41. [Changes in and modulation of receptor activity in hepatic encephalopathy].
    Kienzl E; Riederer P; Brücke T; Kleinberger G; Jellinger K
    Infusionsther Klin Ernahr; 1985 Feb; 12(1):32, 37-45. PubMed ID: 2859245
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacognostic and pharmacological profile of Humulus lupulus L.
    Zanoli P; Zavatti M
    J Ethnopharmacol; 2008 Mar; 116(3):383-96. PubMed ID: 18308492
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Current status of pharmacological receptors in mammalian central nervous system.
    Banerjee PK; Sen AP; Bhattacharya SK
    Indian J Exp Biol; 1989 Apr; 27(4):310-6. PubMed ID: 2553590
    [No Abstract]   [Full Text] [Related]  

  • 44. Commercial valerian interactions with [3H]Flunitrazepam and [3H]MK-801 binding to rat synaptic membranes.
    Ortiz JG; Rassi N; Maldonado PM; González-Cabrera S; Ramos I
    Phytother Res; 2006 Sep; 20(9):794-8. PubMed ID: 16819753
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multiple CNS receptor interactions of ergot alkaloids: affinity and intrinsic activity analysis in in vitro binding systems.
    U'Prichard DC
    Adv Biochem Psychopharmacol; 1980; 23():103-15. PubMed ID: 6249089
    [No Abstract]   [Full Text] [Related]  

  • 46. [Evaluation of the activity on the mouse CNS of several plant extracts and a combination of them].
    Della Loggia R; Tubaro A; Redaelli C
    Riv Neurol; 1981; 51(5):297-310. PubMed ID: 6118937
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Binding of STW 5 (Iberogast) and its components to intestinal 5-HT, muscarinic M3, and opioid receptors.
    Simmen U; Kelber O; Okpanyi SN; Jaeggi R; Bueter B; Weiser D
    Phytomedicine; 2006; 13 Suppl 5():51-5. PubMed ID: 16973340
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A double-blind, placebo-controlled investigation of the effects of two doses of a valerian preparation on the sleep, cognitive and psychomotor function of sleep-disturbed older adults.
    Diaper A; Hindmarch I
    Phytother Res; 2004 Oct; 18(10):831-6. PubMed ID: 15551388
    [TBL] [Abstract][Full Text] [Related]  

  • 49. GR196429: a nonindolic agonist at high-affinity melatonin receptors.
    Beresford IJ; Browning C; Starkey SJ; Brown J; Foord SM; Coughlan J; North PC; Dubocovich ML; Hagan RM
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1239-45. PubMed ID: 9618428
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of valerian on sleep quality in postmenopausal women: a randomized placebo-controlled clinical trial.
    Taavoni S; Ekbatani N; Kashaniyan M; Haghani H
    Menopause; 2011 Sep; 18(9):951-5. PubMed ID: 21775910
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antipsychotic and sedative effects of the leaf extract of Crassocephalum bauchiense (Hutch.) Milne-Redh (Asteraceae) in rodents.
    Sotoing Taïwe G; Ngo Bum E; Talla E; Dawe A; Okomolo Moto FC; Temkou Ngoupaye G; Sidiki N; Dabole B; Djomeni Dzeufiet PD; Dimo T; De Waard M
    J Ethnopharmacol; 2012 Aug; 143(1):213-20. PubMed ID: 22750453
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterisation of the central nervous depressant activity of a commercially available valerian root extract.
    Leuschner J; Müller J; Rudmann M
    Arzneimittelforschung; 1993 Jun; 43(6):638-41. PubMed ID: 8352816
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Determination of ligand binding affinities for endogenous seven-transmembrane receptors using fluorometric microvolume assay technology.
    Mellentin-Michelotti J; Evangelista LT; Swartzman EE; Miraglia SJ; Werner WE; Yuan PM
    Anal Biochem; 1999 Aug; 272(2):182-90. PubMed ID: 10415087
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Brain receptors and zopiclone.
    Blanchard JC; Boireau A; Julou L
    Int Pharmacopsychiatry; 1982; 17 Suppl 2():59-69. PubMed ID: 6329982
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alteration by maternal pinealectomy of fetal and neonatal melatonin and dopamine D1 receptor binding in the suprachiasmatic nuclei.
    Naitoh N; Watanabe Y; Matsumura K; Murai I; Kobayashi K; Imai-Matsumura K; Ohtuka H; Takagi K; Miyake Y; Satoh K; Watanabe Y
    Biochem Biophys Res Commun; 1998 Dec; 253(3):850-4. PubMed ID: 9918818
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An aqueous extract of valerian influences the transport of GABA in synaptosomes.
    Santos MS; Ferreira F; Cunha AP; Carvalho AP; Macedo T
    Planta Med; 1994 Jun; 60(3):278-9. PubMed ID: 8073095
    [No Abstract]   [Full Text] [Related]  

  • 57. Melatonin receptors. An overview for physicians.
    Zee PC
    Postgrad Med; 2004 Dec; 116(6 Suppl Primary):10-3. PubMed ID: 19667693
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors.
    Roth BL; Craigo SC; Choudhary MS; Uluer A; Monsma FJ; Shen Y; Meltzer HY; Sibley DR
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1403-10. PubMed ID: 7908055
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Valerian extract Ze 911 inhibits postsynaptic potentials by activation of adenosine A1 receptors in rat cortical neurons.
    Vissiennon Z; Sichardt K; Koetter U; Brattström A; Nieber K
    Planta Med; 2006 Jun; 72(7):579-83. PubMed ID: 16673319
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anticonvulsant effect of aqueous extract of Valeriana officinalis in amygdala-kindled rats: possible involvement of adenosine.
    Rezvani ME; Roohbakhsh A; Allahtavakoli M; Shamsizadeh A
    J Ethnopharmacol; 2010 Feb; 127(2):313-8. PubMed ID: 19900527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.